MedPath

Investigation effect of oral paracetamol in closing PDA in premature neonates

Not Applicable
Conditions
Patent Ductus Arteriosus.
Patent ductus arteriosus
Registration Number
IRCT20171227038102N1
Lead Sponsor
Tabriz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
90
Inclusion Criteria

preterm neonate
Patent Ductus Arteriosus

Exclusion Criteria

Congenital heart disease afflicted by PDA
Neonates with syndromes
Increased pulmonary arterial pressure with left to right shunt
Neonates who have digestive intolerance

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Closure of Patent Ductus Arteriosus. Timepoint: At the beginning of the study. Method of measurement: By echocardiography.
Secondary Outcome Measures
NameTimeMethod
Side effects. Timepoint: The entire study period. Method of measurement: Serial clinical examinations.
© Copyright 2025. All Rights Reserved by MedPath